World's Best Scientists 2026 revealed!
Eiji Matsuura

Eiji Matsuura

D-Index & Metrics

Immunology

D-Index
65
Citations
15052
World Ranking
2848
National Ranking
119

Overview

Eiji Matsuura is affiliated with Okayama University in Japan. Their research spans multiple fields with a strong focus on Medicine and Biochemistry, Genetics and Molecular Biology. Within these fields, their work often intersects with subfields including Radiology, Nuclear Medicine and Imaging, Molecular Biology, Immunology, Rheumatology, and Biochemistry.

The scientist's work concentrates on various specialized topics. Key research areas include:

  • Radiopharmaceutical Chemistry and Applications
  • Boron Compounds in Chemistry
  • Boron and Carbon Nanomaterials Research
  • Atherosclerosis and Cardiovascular Diseases
  • Systemic Lupus Erythematosus Research
  • Eicosanoids and Hypertension Pharmacology
  • Nanoplatforms for cancer theranostics

Frequent venues for publication in their research career comprise:

  • Cells
  • Heliyon
  • Diabetes Research and Clinical Practice
  • PLoS ONE
  • Journal of Pharmaceutical Sciences

Eiji Matsuura has collaborated regularly with several co-authors, including:

  • Rani Sauriasari
  • Xian Wen Tan
  • Andisyah Putri Sekar
  • Kazuko Kobayashi
  • Takashi Ohtsuki

Among recent publications authored or co-authored by Eiji Matsuura are:

  • "Lactosome-Conjugated siRNA Nanoparticles for Photo-Enhanced Gene Silencing in Cancer Cells," 2021, Journal of Pharmaceutical Sciences
  • "Role of urinary H2O2, 8-iso-PGF2α, and serum oxLDL/β2GP1 complex in the diabetic kidney disease," 2022, PLoS ONE
  • "Antioxidative attributes of rice bran extracts in ameliorative effects of atherosclerosis-associated risk factors," 2020, Heliyon
  • "Novel Self-Forming Nanosized DDS Particles for BNCT: Utilizing A Hydrophobic Boron Cluster and Its Molecular Glue Effect," 2022, Cells
  • "Identification and visualization of oxidized lipids in atherosclerotic plaques by microscopic imaging mass spectrometry-based metabolomics," 2020, Atherosclerosis

Best Publications

  • Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease.

    Eiji Matsuura;Yoshiko Igarashi;Masao Fujimoto;Kenji Ichikawa

  • Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface.

    Eiji Matsuura;Yoshiko Igarashi;Tatsuji Yasuda;Douglas A. Triplett

  • Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases

    Yehuda Shoenfeld;Roberto Gerli;Andrea Doria;Eiji Matsuura

  • Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor.

    E Matsuura;Y Igarashi;M Fujimoto;K Ichikawa

  • Involvement of β2‐glycoprotein I and anticardiolipin antibodies in oxidatively modified low‐density lipoprotein uptake by macrophages

    Y. Hasunuma;Eiji Matsuura;Z. Makita;T. Katahira

  • Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids.

    Yasuhito Honda;Yoshio Kuroki;Eiji Matsuura;Hisato Nagae

  • Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.

    Tatsuya Atsumi;Masahiro Ieko;Maria L. Bertolaccini;Kenji Ichikawa

  • A role for interleukin-2 trans -presentation in dendritic cell–mediated T cell activation in humans, as revealed by daclizumab therapy

    Simone C Wuest;Jehad H Edwan;Jayne F Martin;Sungpil Han;Sungpil Han

  • Oxidation of LDL and its clinical implication.

    Eiji Matsuura;Graham R.V. Hughes;Munther A Khamashta

  • Antibodies to β2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus

    Akito Tsutsumi;Eiji Matsuura;Kenji Ichikawa;Atsushi Fujisaku

  • Circulating oxidized LDL forms complexes with β2-glycoprotein I implication as an atherogenic autoantigen

    Kazuko Kobayashi;Makoto Kishi;Tatsuya Atsumi;Maria L. Bertolaccini

  • Chemical Xenobiotics and Mitochondrial Autoantigens in Primary Biliary Cirrhosis: Identification of Antibodies against a Common Environmental, Cosmetic, and Food Additive, 2-Octynoic Acid

    Katsushi Amano;Patrick S C Leung;Roman Rieger;Chao Quan

  • Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis

    Eiji Matsuura;Kazuko Kobayashi;Masako Tabuchi;Luis R. Lopez

  • Anticardiolipin antibodies in NZW x BXSB F1 mice. A model of antiphospholipid syndrome.

    Y Hashimoto;M Kawamura;K Ichikawa;T Suzuki

  • Are Anti–Oxidized Low-Density Lipoprotein Antibodies Pathogenic or Protective?

    Yehuda Shoenfeld;Yehuda Shoenfeld;Ruihua Wu;Linda D. Dearing;Eiji Matsuura

  • beta 2-Glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome

    Kenji Ichikawa;Munther A. Khamashta;Takao Koike;Eiji Matsuura

  • A specific ligand for β2-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages

    Kazuko Kobayashi;Eiji Matsuura;Qingping Liu;Jun Ichi Furukawa

  • Is atherosclerosis an autoimmune disease

    Eiji Matsuura;Fabiola Atzeni;Piercarlo Sarzi-Puttini;Maurizio Turiel

  • Human beta2-glycoprotein I as an anticardiolipin cofactor determined using mutants expressed by a baculovirus system

    Makoto Igarashi;Eiji Matsuura;Yoshiko Igarashi;Hisato Nagae

  • Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.

    Hiroyuki Takeya;Tatsuyuki Mori;Esteban C. Gabazza;Kenji Kuroda

Frequent Co-Authors

Takao Koike
Takao Koike Hokkaido University
Yehuda Shoenfeld
Yehuda Shoenfeld Sheba Medical Center
Tatsuya Atsumi
Tatsuya Atsumi Hokkaido University
Masataka Kuwana
Masataka Kuwana Nippon Medical School
Keiji Oguma
Keiji Oguma Okayama University
Yasuo Ikeda
Yasuo Ikeda Waseda University
Munther A. Khamashta
Munther A. Khamashta King's College London
Yoshio Kuroki
Yoshio Kuroki Sapporo Medical University
Hirofumi Makino
Hirofumi Makino Okayama University
Miri Blank
Miri Blank Tel Aviv University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in studying Immunology in the USA, exploring related online degrees can open up diverse career opportunities in healthcare and research. One popular pathway is pursuing an accelerated nurse practitioner program. These programs offer a fast-tracked route for healthcare professionals aspiring to advance their clinical roles with a focus on patient care and immunological conditions.

For individuals without a nursing background, starting with the best online RN programs for non nurses can provide a solid foundation in nursing fundamentals while accommodating busy lifestyles. These programs ensure non-nurses gain the essential clinical skills needed to progress toward specialized immunology or healthcare roles.

Additionally, if time is a constraint, many students find 12-month accelerated nursing programs beneficial. These intensive programs allow learners to swiftly acquire a Bachelor of Science in Nursing degree and start applying immunology knowledge in clinical settings.

Those seeking entry-level positions might consider exploring which LPN programs are easiest to get into. Licensed Practical Nurse programs often serve as stepping stones to build practical experience before advancing to higher immunology-focused degrees.

Best Scientists Citing Eiji Matsuura

Trending Scientists